» Articles » PMID: 34001255

Heat Shock Preconditioning Mesenchymal Stem Cells Attenuate Acute Lung Injury Via Reducing NLRP3 Inflammasome Activation in Macrophages

Overview
Publisher Biomed Central
Date 2021 May 18
PMID 34001255
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Acute lung injury (ALI) remains a common cause of morbidity and mortality worldwide, and to date, there is no effective treatment for ALI. Previous studies have revealed that topical administration of mesenchymal stem cells (MSCs) can attenuate the pathological changes in experimental acute lung injury. Heat shock (HS) pretreatment has been identified as a method to enhance the survival and function of cells. The present study aimed to assess whether HS-pretreated MSCs could enhance immunomodulation and recovery from ALI.

Materials And Methods: HS pretreatment was performed at 42 °C for 1 h, and changes in biological characteristics and secretion functions were detected. In an in vivo mouse model of ALI, we intranasally administered pretreated umbilical cord-derived MSCs (UC-MSCs), confirmed their therapeutic effects, and detected the phenotypes of the macrophages in bronchoalveolar lavage fluid (BALF). To elucidate the underlying mechanisms, we cocultured pretreated UC-MSCs with macrophages in vitro, and the expression levels of inflammasome-related proteins in the macrophages were assessed.

Results: The data showed that UC-MSCs did not exhibit significant changes in viability or biological characteristics after HS pretreatment. The administration of HS-pretreated UC-MSCs to the ALI model improved the pathological changes and lung damage-related indexes, reduced the proinflammatory cytokine levels, and modulated the M1/M2 macrophage balance. Mechanistically, both the in vivo and in vitro studies demonstrated that HS pretreatment enhanced the protein level of HSP70 in UC-MSCs, which negatively modulated NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in alveolar macrophages. These effects were partially reversed by knocking down HSP70 expression.

Conclusion: HS pretreatment can enhance the beneficial effects of UC-MSCs in inhibiting NLRP3 inflammasome activation in macrophages during ALI. The mechanism may be related to the upregulated expression of HSP70.

Citing Articles

Engineered EVs from LncEEF1G - overexpressing MSCs promote fibrotic liver regeneration by upregulating HGF release from hepatic stellate cells.

Zhang J, Qiu X, Lei Y, Chen H, Wu D, Wang T Exp Mol Med. 2025; .

PMID: 40025174 DOI: 10.1038/s12276-025-01413-4.


Human fetal lung mesenchymal stem cells ameliorate lung injury in an animal model.

Golmohammadi M, Sheikhha M, Ganji F, Shirani A, Barati M, Kalantar S Sci Rep. 2025; 15(1):6433.

PMID: 39984612 PMC: 11845704. DOI: 10.1038/s41598-025-91406-0.


Placental mesenchymal stem cells suppress inflammation and promote M2-like macrophage polarization through the IL-10/STAT3/NLRP3 axis in acute lung injury.

Nie Z, Fan Q, Jiang W, Wei S, Luo R, Hu H Front Immunol. 2024; 15:1422355.

PMID: 39620220 PMC: 11604576. DOI: 10.3389/fimmu.2024.1422355.


Methylation of TTC4 interaction with HSP70 inhibits pyroptosis in macrophages of sepsis-induced lung injury by NLRP3 inflammation.

Chen P, Liu J, Sun K, Wang L, Li X, Li X Am J Cancer Res. 2023; 13(11):5122-5137.

PMID: 38058818 PMC: 10695783.


Conservative Hypomethylation of Mesenchymal Stem Cells and Their Secretome Restored the Follicular Development in Cisplatin-Induced Premature Ovarian Failure Mice.

Nabil Salama A, Badr E, Holah N, El Barbary A, Hessien M Reprod Sci. 2023; 31(4):1053-1068.

PMID: 37957472 PMC: 10959784. DOI: 10.1007/s43032-023-01389-4.


References
1.
Ben Salem C . Acute Respiratory Distress Syndrome. N Engl J Med. 2017; 377(19):1904. DOI: 10.1056/NEJMc1711824. View

2.
Matute-Bello G, Downey G, Moore B, Groshong S, Matthay M, Slutsky A . An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011; 44(5):725-38. PMC: 7328339. DOI: 10.1165/rcmb.2009-0210ST. View

3.
Shotland A, Fontenot A, McKee A . Pulmonary Macrophage Cell Death in Lung Health and Disease. Am J Respir Cell Mol Biol. 2020; 64(5):547-556. PMC: 8086041. DOI: 10.1165/rcmb.2020-0420TR. View

4.
Bellani G, Laffey J, Pham T, Fan E, Brochard L, Esteban A . Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016; 315(8):788-800. DOI: 10.1001/jama.2016.0291. View

5.
Li S, Zheng X, Li H, Zheng J, Chen X, Liu W . Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment. J Immunol Res. 2019; 2018:7283703. PMC: 6304871. DOI: 10.1155/2018/7283703. View